Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-037149
Filing Date
2021-09-22
Accepted
2021-09-22 18:51:08
Documents
1
Period of Report
2021-09-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3706
  Complete submission text file 0000899243-21-037149.txt   5060
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Issuer) CIK: 0001783328 (see all company filings)

EIN.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O TSCAN THERAPEUTICS, INC. 830 WINTER STREET WALTHAM MA 02451
Business Address
Silver Brian M. (Reporting) CIK: 0001860597 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40603 | Film No.: 211270545